# Safety and Efficacy of CDB-2914 for Emergency Contraception

> **NCT00411684** · PHASE3 · COMPLETED · sponsor: **HRA Pharma** · enrollment: 1623 (actual)

## Conditions studied

- Emergency Contraception

## Interventions

- **DRUG:** CDB-2914

## Key facts

- **NCT ID:** NCT00411684
- **Lead sponsor:** HRA Pharma
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2006-11
- **Primary completion:** 2008-04-08
- **Final completion:** 2009-06-05
- **Target enrollment:** 1623 (ACTUAL)
- **Last updated:** 2021-09-21


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00411684

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00411684, "Safety and Efficacy of CDB-2914 for Emergency Contraception". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT00411684. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*